Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?

In the last 5 years, guidelines have been developed for performing cost-effectiveness analyses (CEAs) for the economic evaluation of vaccination programs against infectious diseases. However, these cost-effectiveness guidelines do not provide specific guidance for including the value of reducing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauskopf, Josephine, Masaquel, Catherine, Huang, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. 2021
Materias:
Themed Section: Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550269/
https://www.ncbi.nlm.nih.gov/pubmed/33431158
http://dx.doi.org/10.1016/j.jval.2020.06.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550269/
https://www.ncbi.nlm.nih.gov/pubmed/33431158
http://dx.doi.org/10.1016/j.jval.2020.06.018

Ejemplares similares